diff options
| -rw-r--r-- | README.md | 5 | ||||
| -rw-r--r-- | docs/2021.10.24.465626v1.full.pdf | bin | 0 -> 4187781 bytes |
2 files changed, 4 insertions, 1 deletions
@@ -54,7 +54,7 @@ $ curl https://corona-stats.online/ ## Docs | Name | SRC link | Local link | Language | -| :---------------------------------------------------------------------------------------------------------------------------------------------------------------------: | :--------: | :--------: | :------: | +|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------:|:----------:|:----------:|:--------:| | COVID-19: IFRC, UNICEF and WHO issue guidance to protect children and support safe school operations | [URL][d0] | [URL][l0] | EN | | How Long Should Social Distancing Last? Predicting Time to Moderation, Control, and Containment of COVID-19 | [URL][d1] | [URL][l1] | EN | | Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 | [URL][d2] | [URL][l2] | EN | @@ -66,6 +66,7 @@ $ curl https://corona-stats.online/ | Sentinel surveillance of SARS-CoV-2 in wastewater anticipates the occurrence of COVID-19 cases | [URL][d8] | [URL][l8] | EN | | Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia | [URL][d9] | [URL][l9] | EN | | A phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS-COV-2rna vaccine candidates against COVID-19 in healthy individuals | [URL][d10] | [URL][l10] | EN | +| SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19 | [URL][d11] | [URL][l11] | EN | ## Vaccine @@ -138,6 +139,8 @@ title="GNU Free Documentation License">GFDLv1.3+</abbr></a> License [l9]: docs/PIIS0140673621002348.pdf [d10]: https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-11/C4591001_Clinical_Protocol_Nov2020.pdf [l10]: docs/C4591001_Clinical_Protocol_Nov2020.pdf +[d11]: docs/Key-Messages-and-Actions-for-COVID-19-Prevention-and-Control-in-Schools_March-2020.pdf +[l11]: https://www.biorxiv.org/content/10.1101/2021.10.24.465626v1.full.pdf [vac1]: docs/ModeRNA.pdf [vac2]: docs/Pfizer-BioNTech.pdf [vac3]: docs/Sputnik_V.pdf diff --git a/docs/2021.10.24.465626v1.full.pdf b/docs/2021.10.24.465626v1.full.pdf Binary files differnew file mode 100644 index 0000000..fa60cc5 --- /dev/null +++ b/docs/2021.10.24.465626v1.full.pdf |